Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

about

Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma

P2860

Q58693451-18216ED9-0824-4BA3-B991-756A25AC859A

P2860

Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

Item

http://www.wikidata.org/entity/Q49168184

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Significant expression of CHK1 ...... apeutic targets and prognosis.

@en

Significant expression of CHK1 ...... apeutic targets and prognosis.

@nl

type

Item

label

Significant expression of CHK1 ...... apeutic targets and prognosis.

@en

Significant expression of CHK1 ...... apeutic targets and prognosis.

@nl

prefLabel

Significant expression of CHK1 ...... apeutic targets and prognosis.

@en

Significant expression of CHK1 ...... apeutic targets and prognosis.

@nl

P1476

Significant expression of CHK1 ...... apeutic targets and prognosis.

@en

P2093

Guoping Cheng

http://www.w3.org/2001/XMLSchema#string

Lei Lei

http://www.w3.org/2001/XMLSchema#string

Linfeng Zheng

http://www.w3.org/2001/XMLSchema#string

Shifeng Yang

http://www.w3.org/2001/XMLSchema#string

Wenyong Sun

http://www.w3.org/2001/XMLSchema#string

Yuping Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugs

Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy

The genetics of the p53 pathway, apoptosis and cancer therapy.

p53 in the DNA-Damage-Repair Process

ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.

Chk1 promotes replication fork progression by controlling replication initiation.

microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.

Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase.

Inverse relationship between p53 and phospho-Chk1 (Ser317) protein expression in UVB-induced skin tumors in SKH-1 mice

Mutant p53: one name, many proteins.

P304

568-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7344

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29391889

http://www.w3.org/2001/XMLSchema#string

P932

5769388

http://www.w3.org/2001/XMLSchema#string

Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

about

P2860

P2860

Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932